Mechanisms underlying pioneer TF-mediated gene repression
Researchers have made surprising and important findings that may influence organoid and cell reprogramming studies.
List view / Grid view
Researchers have made surprising and important findings that may influence organoid and cell reprogramming studies.
Researchers explored the effects of loops and 3D genome organisation on gene silencing, and found that ‘cohesinopathies’ may be linked it.
The ML algorithm explores how genetic mutations collectively influence a tumour’s reaction to drugs impeding DNA replication.
Disruptions in TP53 and RB1 are key influencers that cause changes in the risk of mutations across chromosomes.
Cancer treatment may be majorly impacted by new findings about the polymerase theta-mediated end joining time DNA repair pathway.
Researchers have found what triggers bacteria to start the CBASS immune response to counter infections by phages.
Researchers, using high-resolution mapping and mathematical modelling, have found mechanisms controlling mutation-driven diseases.
Researchers have completely decoded the human Y chromosome, which may result in more effective treatment for digestive disorders.
Researchers have developed an AI based model that is 80 percent accurate in predicting the therapy outcome of high-grade ovarian cancer.
Researchers find that polymerase epsilon exonuclease is an essential target for cancer diagnosis and treatments that rely on DNA damage.
Scientists find a way to slow the progression of Huntington’s disease by analysing DNA and find the basis of a potential treatment.
Researchers pinpoint connections of risk variants with microglia functions that are important for Alzheimer’s disease (AD).
Researchers find genetic explanation for increased risk of developing second cancers.
This September edition of our Women in Stem series spotlights Dr Emily Leproust, CEO of Twist Bioscience. Dr Leproust began her STEM journey from a background in chemistry, eventually leading her to the forefront of DNA synthesis technology. She co-founded Twist Bioscience in 2013, now a thriving company reporting substantial…
A collaborative team has uncovered a method to extend the functionality of CAR-T cells.